Related by context. All words. (Click for frequent words.) 83 candidate Zemiva TM 82 targeted radiotherapeutic 81 lead molecular radiotherapeutic 80 candidate Zemiva 79 candidates Azedra 79 Zemiva TM 78 Personalized Immunotherapy 78 acetonide FA 78 Solazed TM 78 candidates Azedra TM 77 candidate deforolimus 77 Onalta 77 Initiates Enrollment 76 topically applied SEPA 76 investigational pharmacologically unique 76 PDX pralatrexate 75 Perflubutane Polymer Microspheres 75 delivers fluocinolone acetonide FA 75 Files IND 75 bucindolol hydrochloride 75 Panzem R 75 PNP inhibitor 75 ALTROPANE R 75 polysaccharide polymer 75 candidate ridaforolimus 75 ALN PCS 74 methylnaltrexone bromide 74 muscarinic receptor agonist 74 Receives Orphan Drug Designation 74 mitogen activated ERK kinase 74 Solazed ™ 74 Iluvien ® 74 SinuNase TM 74 Zemiva ™ 74 MKC# MKC# PP 74 Completes Patient Enrollment 74 intranasal formulation 74 include PLX IBD 73 Onalta TM 73 candidate MyVax 73 Xcytrin R 73 targeting Inflammatory Bowel 73 Generx TM 73 Onalta ™ 73 vapreotide acetate 73 Initiates Clinical Trial 73 Initiates Phase II 73 Initiate Clinical Trial 73 overactive bladder AA# 73 personalized cellular immunotherapy 73 SPL# Gel vaginal microbicide 73 candidate TNFerade biologic 73 Injectable Suspension 73 Presents Preclinical Data 73 TELINTRA R 73 Factor VIIa 73 ocular formulation 73 Auxilium transmucosal film 73 oncolytic virus therapies 73 oral prodrug 72 Intravenous Human 72 rxRNA 72 Opterone R 72 treat chronic sinusitis 72 diagnostic radiopharmaceutical 72 Kuvan TM sapropterin 72 BiovaxID TM 72 mild vasodilator 72 Alfacell proprietary ribonuclease 72 using VIAdel TM 72 Prodarsan R 72 AAG geldanamycin analog 72 Tezampanel 72 Generx ™ 72 Angiocept 72 Augment TM 72 topical anti infective 72 anti infective treatments 72 HuMax TAC 72 investigational humanized monoclonal antibody 72 Initiates Clinical 72 Azedra TM Onalta TM 72 2 methoxyestradiol 72 KL4 Surfactant 72 FOLOTYN ® 72 sapropterin dihydrochloride 72 Begins Dosing 72 markets HP Acthar 72 GVAX ® 72 proprietary intranasal insulin 72 Vascular Disrupting Agent 71 HepeX B TM 71 candidate XP# 71 highly purified pasteurized 71 M# rationally 71 TRANSDUR ® 71 novel oral anticoagulant 71 ELADUR TM 71 selective immunoproteasome inhibitor 71 acyclovir Lauriad R 71 non nucleoside inhibitor 71 Receives Orphan Drug 71 THR beta agonist 71 IL# PE#QQR 71 oxybutynin ATD TM 71 Disease IBD 71 lexidronam injection 71 ZEVALIN ® 71 candidate Zenvia 71 CB2 selective receptor agonist 71 SinuNase ™ 71 CD# CEA 71 HDL Mimetic Peptide 71 candidate Gencaro TM 71 Luveris R Ovidrel R 71 vitreoretinal disorders 71 TRACON Pharmaceuticals 71 Hsp# Inhibitor 71 Liprotamase 71 orBec R oral beclomethasone 71 Unit Dose Budesonide 71 Initiates Phase III 71 intravenous acetaminophen 71 Oracea TM 71 include Phenoptin TM 71 mGluR5 negative 71 non porcine pancreatic 71 ionotropic glutamate receptor antagonists 71 selective estrogen receptor modulator 71 Cleviprex TM clevidipine 71 PDE4 inhibitor 71 XL# anticancer compounds 71 TOCOSOL 71 IMPDH inhibitor 71 FUSILEV ® 71 5 HT3 antagonist 71 Aganocide 70 virus HCV protease inhibitor 70 CYT# potent vascular disrupting 70 Thrombin topical Recombinant 70 novel MetAP 2 70 Receives Approvable Letter 70 BEMA Granisetron 70 Crofelemer budesonide foam 70 REG1 Anticoagulation System 70 CRMD# 70 RECOTHROM ® 70 MOVIPREP R 70 candidate AQ4N 70 inflammatory autoimmune diseases 70 Locteron ® 70 novel L DOS# 70 Phase 2a clinical trials 70 XP# XP# 70 EVIZON TM 70 Zorbtive TM 70 TM Aganocide 70 Orally administered 70 targets Galectin receptors 70 orally administered inhibitor 70 TRO# 70 Phase #b/#a clinical 70 ospemifene 70 XmAb ™ 70 hyaluronidase enzyme 70 OvaRex R 70 novel histone deacetylase 70 Meets Primary Endpoint 70 Vitrasert R 70 investigational pan BCR 70 Veronate R 70 motexafin gadolinium Injection 70 PANVAC VF 70 candidate iSONEP TM 70 compound perifosine 70 Intermezzo ® zolpidem tartrate 70 pralatrexate injection folate analogue 70 candidate ATHX 70 investigational antiplatelet agent 70 acne impetigo 70 Submits NDA 70 candidate NGX 70 rusalatide acetate 70 Gets FDA Clearance 70 include Altastaph TM 70 aldehyde dehydrogenase ALDH2 deficiency 70 R Saizen R 70 Drug Candidate 70 sterile lidocaine patch 70 JAK2 Inhibitor 70 TRANSDUR ™ 70 modified glutathione analog 70 liposomal formulation 70 MKC# MT 70 Soliris eculizumab 70 Phase 2b Clinical Trial 70 refractory chronic lymphocytic 70 orBec ® oral beclomethasone 70 aerosolized AAT 70 Inhalation Aerosol 70 OTCBB HXBM developer 70 targeted antifolate 70 hypoxia activated prodrug 70 Staphylococcus aureus Immune Globulin 70 treat refractory angina 70 oral proteasome inhibitor 70 nephropathic cystinosis 70 EVIZON ™ 70 intranasal insulin product 70 investigational mTOR inhibitor 70 Annamycin 70 VIVITROL ® 70 PEGylated interferon 70 tiapamil 70 Nicotine Conjugate Vaccine 70 Serostim ® 70 PHX# 70 Nektar proprietary 70 anti botulism antibody 70 TBC# 70 ELADUR ™ 70 inhibitor PPI 70 sapropterin dihydrochloride Phase 70 histone deacetylase HDAC inhibitor 69 AFREZZA TM 69 Presents Positive 69 Azedra TM 69 Adagen ® 69 Therapeutic Competitors Companies 69 subsidiaries visit http:/www.apricusbio.com 69 Iluvien TM 69 Marqibo TM 69 DURIN TM 69 Licenses Novel 69 DPX Survivac 69 therapeutic monoclonal antibody 69 Files Investigational 69 delivery polymer matrix 69 Pegloticase 69 Announce License Agreement 69 Squalamine 69 product Fentanyl TAIFUN 69 AFREZZA ® 69 S1P antibody 69 catheter occlusion 69 Zemiva TM Trofex TM 69 Trofex ™ 69 Myocet 69 POSIDUR TM ELADUR TM 69 XL# XL# 69 Vascular Wrap TM 69 successfully commercialize Iluvien 69 PROVENGE ® 69 Phase IIb clinical trials 69 Exherin 69 treat male hypogonadism 69 Gel repository corticotropin injection 69 generation purine nucleoside 69 Valtropin 69 VISICOL R 69 TLK# 69 NDA Submission 69 Pruvel TM 69 LEVADEX TM 69 Polymer Microspheres 69 Granted Orphan Drug 69 kidney urologic 69 RhuDex ® 69 JZP 69 rheumatoid arthritis thrombocytopenia 69 evaluating picoplatin 69 Cardium Therapeutics TM 69 NU# direct 69 peripherally acting 69 HepeX B 69 IMiDs R 69 immunotherapeutic agent 69 JAK2 inhibitor 69 including eniluracil ADH 69 orally inhaled migraine 69 mertansine 69 Immunotherapeutic 69 COLAZAL R 69 reslizumab 69 product platforms AZX# 69 OTCBB CVBT 69 PEGylated anti 69 Anturol ® 69 RNAi Therapeutic 69 proprietary polysaccharide 69 Aflibercept 69 BUPHENYL R 69 IMA# 69 NicVAX TM 69 NASH Huntington 69 Gonal f R 69 Sphingomab TM 69 beta 1a 69 Achieves Primary Endpoint 69 ASONEP TM 69 telomerase therapeutic 69 sodium Injection 69 receptor tyrosine kinase inhibitor 69 isoform selective 69 R sorafenib tablets 69 apomorphine hydrochloride 69 Civacir 69 Trofex 69 Xyfid TM 69 iSONEP ™ 69 Alvine Pharmaceuticals 69 TOCOSOL Camptothecin 69 Elagolix 69 proprietary intravenous formulation 69 PORxin TM 69 Announces Poster Presentations 69 thrombin component 69 Homspera TM 69 dasatinib Sprycel 69 Cannabinor 69 metaglidasen 69 NYSE Amex PBTH 69 GLP1 INT TM 69 Wafer polifeprosan 69 MCSP respectively 69 Tumour Vascular Disrupting Agent 69 Campath ® 68 ABL inhibitor 68 BCG refractory carcinoma 68 recombinant biopharmaceutical 68 FDA APPROVES 68 Ostabolin C TM 68 OMNARIS HFA 68 selective androgen receptor modulator 68 lintuzumab SGN 68 Phase III Clinical Trial 68 iSONEP TM 68 topical non steroidal 68 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 68 vinorelbine tartrate 68 Friedreich Ataxia FRDA 68 Completes Enrollment 68 proprietary HuCNS SC 68 Empatic TM 68 Trofex TM 68 AN# novel 68 CYT# vascular disrupting 68 Aloxi ® 68 Locked Nucleic Acid 68 Excellarate TM 68 StaphVAX R 68 zolpidem tartrate sublingual tablet 68 PORxin TM platforms 68 TRANSDUR Bupivacaine 68 Ovitrelle R Serostim 68 anticancer compound 68 essential thrombocythemia ET 68 Presents Preclinical 68 product candidate Lpathomab 68 EVIZON TM squalamine lactate 68 cetuximab Erbitux R 68 BYETTA ® 68 allosteric modulator NAM 68 Myolimus 68 JOULFERON 68 Transdermal Patch 68 Silodosin 68 dasatinib Sprycel ® 68 pseudobulbar affect PBA 68 commercializing therapeutic 68 oral beclomethasone dipropionate 68 psoriasis rheumatoid arthritis 68 Surfaxin LS 68 Reports Preclinical Data 68 dihydrochloride Phase 3 68 Acetavance TM intravenous acetaminophen 68 PEGylated Fab fragment 68 MT# MEDI 68 candidate REP# 68 PARI Pharma GmbH 68 DURECT proprietary 68 Pivotal Phase III 68 Phase IIb Trial 68 topical emulsion 68 lucinactant 68 Initiates Clinical Trials 68 FACTIVE R gemifloxacin 68 R MSCRAMM 68 Doripenem 68 radiation sensitizer 68 volociximab 68 highly selective adenosine 68 Adnectin 68 oral nucleoside analogue 68 Panzem ® 68 DosePro TM 68 Archexin 68 KAI Pharmaceuticals 68 OMAPRO ™ 68 mGluR2 positive 68 Investigational Oral 68 EcoNail TM 68 Peginterferon alfa 2b 68 Corixa Corporation 68 drug ISA# 68 Spiegelmer ® 68 NPC 1C 68 Pafuramidine 68 RECOTHROM R 68 Nasdaq VNDA 68 Therapeutic Competitors companiesandmarkets.com adEgemonye 68 Hematide ™ peginesatide 68 XmAb ® 68 RELISTOR ® 68 infectious diseases autoimmune diseases 68 Submits Biologics License Application 68 histamine dihydrochloride 68 candidate brentuximab vedotin 68 platform HDL Mimetic 68 muscarinic receptor agonists 68 Promedior 68 Aviptadil 68 TLR9 agonist 68 acetylgalactosamine 6 68 Collategene 68 personalized dendritic 68 PrevOnco 68 IMiDs ® 68 personalized immunotherapy 68 PF # [002] 68 PROSTASCINT R 68 Panzem R NCD 68 romidepsin novel 68 Present Preclinical Data 68 RNAi therapeutic targeting 68 Amigal TM 68 Daclizumab 68 thalidomide Thalomid 68 NeutroPhase TM 68 Meritage Pharma 68 brand ciclesonide HFA 68 Neutrolin ® 68 HQK 68 vaccines oncolytic virus 68 Unigene nasal calcitonin 68 AMEX ISV 68 ALN HPN 68 PLK1 SNALP 68 Ecallantide 68 Vidaza R 68 Zenvia ™ 68 outlicensed 68 Kuvan R 68 pan histone deacetylase 68 ILUVIEN ® 68 dihydrochloride 68 Evoltra ® 68 Trodusquemine MSI 68 accumulate preferentially 68 developing Zerenex ferric 68 NUEDEXTA ™ 68 Successfully Completes Phase 68 oral dihydropyrimidine dehydrogenase DPD 68 ATRA IV 68 Enrolls First 68 seliciclib CYC# 68 Therapeutic Vaccine 68 Solazed 68 Hybridon 68 ALN TTR 68 Gastrointestinal Liner 68 TKB# 68 KRYSTEXXA TM pegloticase 68 humanized monoclonal 68 Bucindolol 68 humanized therapeutic 68 personalized dendritic cell 68 OMP #R# 67 ALVESCO ® 67 proteasome inhibitor 67 anti CD3 monoclonal 67 PDE4 modulators 67 monoclonal antibody conjugated 67 PEGylation technology 67 Inc Therapeutic Competitors 67 NeuroSTAT ® 67 Investigational Treatment 67 Juvaris BioTherapeutics 67 PGL# 67 visit www.genenews.com 67 PI3K/Akt pathway inhibitor 67 KNS # 67 Affilin ® 67 Cloretazine ® 67 Regado Biosciences 67 Prism Pharmaceuticals 67 Aganocide ® 67 novel therapeutic antibodies 67 radiotherapeutic 67 Chemokine Therapeutics 67 dextofisopam 67 vaginally administered lidocaine 67 AMEX KAL 67 Maxy G# 67 Celator 67 oral picoplatin 67 LymphoStat B TM 67 reformulates existing FDA 67 R lenalidomide 67 Akesis Pharmaceuticals 67 Neo Urinary Conduit 67 molecular imaging radiopharmaceuticals 67 IMiDs ® compound 67 SABER ™ 67 markets COLAZAL 67 REPRONEX R menotropins 67 candidate Liposomal Grb 67 inhaled liposomal ciprofloxacin 67 Omacetaxine 67 telomerase inhibitor drug 67 FDA Accepts 67 Submits Response 67 Receives Fast Track 67 LibiGel ® 67 candidate AP# 67 MyVax ® 67 Ceplene TM 67 Soliris TM eculizumab 67 pipeline GlycoPEG GCSF 67 Announces Tentative Approval 67 Oral NKTR 67 Solzira TM 67 vinca alkaloid 67 antibody MAb 67 Initiates Dosing 67 CTAP# Injection 67 ATL# [002] 67 ALN TTR# 67 Indaflex TM 67 Novolimus 67 Rhucin ® recombinant 67 Metastatic Melanoma 67 JAK1 67 Nasdaq HALO biopharmaceutical 67 OTCBB PYTO 67 sapropterin dihydrochloride Tablets 67 IRX 2 67 commercializing anti infective 67 Announces FDA Clearance 67 Kosan dependence 67 Aerosurf 67 novel VDA molecule 67 Novel Oral 67 Clolar ® 67 Aurora Kinase 67 CORTOSS R 67 oral anti arrhythmic 67 Captisol ® 67 IAP inhibitors 67 Patient Enrollment 67 DUROS 67 Inc. OTCBB MIVT 67 Allovectin 7 67 KALBITOR ® 67 ThermoDox R 67 VitiGam 67 commercialize Aganocides 67 Romidepsin 67 molecular chaperone regulation 67 Telik logo TELINTRA 67 Small Molecule 67 Generx ® 67 R bortezomib 67 ADP receptor antagonist 67 ZARS Pharma 67 topical gel formulation 67 polymer conjugate technology 67 novel RNAi therapeutics 67 TNF Tumor Necrosis Factor 67 patented Bioral 67 TKM ApoB 67 Panzem NCD 67 proprietary PEGylation 67 Dyloject TM 67 Icatibant 67 Alexza Staccato 67 Bazedoxifene 67 Xanafide 67 CCR9 antagonist 67 TOCOSOL R 67 dextromethorphan quinidine 67 SAR# [002] 67 Nasdaq HALO 67 Awarded Qualifying Therapeutic 67 Fx #A 67 prokinetic agent 67 ONSOLIS TM 67 Tarmogen 67 MEK Inhibitor 67 Inhalation Solution 67 NeutroSpec TM 67 AS# amonafide L malate 67 inhalation aerosol 67 sores onychomycosis nail 67 delivers sumatriptan 67 nasal calcitonin product 67 LE SN# 67 including thyroiditis RA 67 developing Bicifadine serotonin 67 IgG1 monoclonal antibody 67 acute peripheral arterial 67 label Lipofen R 67 Eluting Coronary Stent System 67 Hematide TM 67 Intarcia 67 PARI Pharma 67 small molecule tyrosine 67 Nipent R 67 Nexavar sorafenib tablets 67 FS Antihemophilic Factor Recombinant 67 PRT# 67 VentiRx Pharmaceuticals 67 Exelixis compounds 67 octreotide implant 67 Pathway Inhibitor 67 corticotropin injection 67 BRILINTA 67 molecular therapeutics immunotherapies 67 IV Busulfex 67 derivatives Radilex TM 67 ProtAffin 67 commercialize deforolimus ARIAD 67 AzaSite Plus 67 using Innocoll proprietary 67 interferon beta 1a infertility 67 candidate HuCNS SC 67 Omigard TM 67 Genasense ® oblimersen 67 candidate epratuzumab 67 UltiMAb 67 Lenocta TM 67 Combination REOLYSIN R 67 transthyretin mediated amyloidosis ATTR 67 vaccine GRNVAC1 67 candidate CRLX# 67 human C1 inhibitor 67 neuropathic pain metabolic diseases 67 sodium thiosulfate STS 67 Savella ® 67 either acutely decompensated 67 Sopherion 67 lexidronam injection PROSTASCINT 67 R bendamustine hydrochloride 67 Captisol enabled 67 Anidulafungin 67 Recombinant Human 67 albiglutide 67 NUVIGIL ® 67 Phase IIb Clinical Trial 67 AzaSite Xtra 67 oral dual endothelin 67 include GALNS N 67 Aloxi R 67 Cintredekin Besudotox 67 includes TOLAMBA TM 67 Catalyst Biosciences 67 Allovectin 7 r 67 Hedgehog Pathway Inhibitor 67 hormone LHRH antagonist 67 NasdaqGM SPPI 67 HepaSphere 67 WeissComm Partners +#-#-#-# 67 Receives Milestone Payment 67 novel peptide 67 oral Factor Xa 67 Pyridorin 67 relapsed leukemia 67 Tibotec Therapeutics division 67 sodium glucose transporter 67 EP #R 67 mesylate tablets approved 67 CTAP# Capsules 67 Initiates Phase 2b 67 inhaled formulation 66 Submits IND 66 FDA Approvals 66 induced macular edema 66 MKC# 66 Diabetic Macular Edema DME 66 Vivecon 66 DepoCyt ® Abelcet ® 66 mocetinostat MGCD# 66 PSN# [001] 66 IV acetaminophen 66 intravenous recombinant 66 dihydrochloride Tablets 66 DELATESTRYL R 66 Safinamide 66 cutaneous T 66 Demonstrates Significant 66 Hematide ™ 66 Nutra Pharma wholly owned 66 antiangiogenesis therapies 66 Qutenza TM 66 RenaZorb TM 66 Modrenal R 66 apricitabine ATC 66 Phase 2a Clinical Trial 66 oral salmon calcitonin 66 PRN FDA Approves 66 topically delivered 66 AERx R 66 phenylalanine ammonia lyase 66 SCIB1 66 Ph.D. Targacept 66 treat opioid induced 66 sublingual tablet formulation 66 RANK Ligand inhibitor 66 CEQ# 66 BEMA TM Fentanyl 66 Molecular Insight 66 Empatic ™ 66 FOLFOX6 chemotherapy regimen 66 phase III isavuconazole 66 neuro inflammatory 66 Lixivaptan 66 BioSante Pharmaceuticals Announces 66 Xytis 66 Onconase 66 IMiD 66 TELINTRA 66 R PEG uricase 66 SIX RO ROG 66 platinum chemotherapeutic 66 SUTENT ® 66 VALSTAR TM 66 coronary stent merged 66 Cardioxyl Pharmaceuticals 66 peptidic compound 66 OTC BB PVCT 66 IMPACS R 66 Fortical R 66 vascular disrupting agent 66 Vitamin D analogue 66 ELND-#/AZD-# 66 please visit http:/www.vandapharma.com 66 Provectus Pharmaceuticals specializes 66 Bone Augmentation Material 66 ORADUR ® 66 erlotinib Tarceva ® 66 Tesetaxel 66 Initiates Phase 66 GTC NASDAQ GTCB 66 Orphan Drug designations 66 humanised monoclonal antibody 66 Troxatyl 66 Shows Statistically Significant 66 Saizen R 66 highly selective inhibitor 66 Oral Spray 66 HyperAcute 66 Kinase Inhibitor 66 Resurgex Plus 66 Supernus Pharmaceuticals 66 Ophthotech 66 candidates bavituximab 66 Dual Opioid TM 66 Nasdaq XTLB 66 Naglazyme R 66 DOS# 66 Cetrorelix 66 sapacitabine CYC# 66 DPP4 inhibitor 66 Inc. Nasdaq AVRX 66 Targeted Chemotherapy 66 Ketotransdel 66 Protexia ® 66 Duromist ™ 66 prescribed proton pump 66 ProEthic Pharmaceuticals 66 Mg Usa 66 OTCBB OHRP 66 NAVISTAR R 66 COX Inhibiting Nitric Oxide 66 MEK inhibitor 66 humanized anti 66 IAP inhibitor 66 Maribavir 66 Cypher Sirolimus 66 Proquin XR 66 Altera Nebulizer System 66 DNA methyltransferase inhibitors 66 selective adenosine 66 proprietary radiolabeled monoclonal 66 Fludara ® 66 intranasal vaccines derived 66 aripiprazole Abilify 66 diabetes irritable bowel 66 INSPIRE Trial Phase III 66 VALSTAR 66 Zolpimist ™ 66 Guanilib 66 HCV protease inhibitor 66 biomodulator 66 Selective Electrochemical Tumor Ablation 66 RONDEL ™ 66 ATPace TM 66 glucokinase activator 66 HEPLISAV ™ 66 pregabalin Lyrica 66 PrevOnco ™ 66 Simulect 66 HP Acthar R 66 ZANAFLEX CAPSULES ® tizanidine 66 overactive bladder VANTAS R 66 IV APAP 66 DermTech International 66 candidate EFAPROXYN TM 66 Peyronie disease Frozen Shoulder 66 2 inhibitor CYT# 66 Phase 2b Trial 66 DG# compounds targeting 66 Aryplase 66 Entereg R 66 Arno Therapeutics 66 Cerimon 66 SmartChip TM 66 Inc. AMEX YMI 66 CA9 SCAN 66 orally inhaled 66 oncology therapeutics 66 highly selective endothelin 66 Delipidation 66 novel antibody therapeutics 66 NEBIDO R 66 systemic anaplastic large 66 topical dermatology 66 PEG irinotecan 66 adenosine injection 66 sodium sulfate sodium chloride 66 Biolex Therapeutics 66 Posiphen TM 66 MAb therapy 66 Emezine 66 use transdermal sumatriptan 66 Besivance 66 class anticancer quinolone 66 ASONEP ™ 66 Microwave Ablation System 66 Presents Positive Preclinical 66 novel immunotherapies 66 topical antifungal product 66 immuno inflammatory diseases 66 ACAPODENE TM 66 Idera Pharmaceuticals 66 Nabi HB ® 66 Nasdaq PARD 66 Cutanea Life Sciences 66 JAK inhibitor 66 Breast Cancer Assay 66 Aeolus Pharmaceuticals Announces 66 metastatic malignant 66 compound ISA# 66 GlycoPEGylated hemostasis compounds 66 RELOVAIR ™ 66 Emollient Foam 66 Gliadel R 66 Syncria R 66 Ceflatonin R 66 Ridaforolimus 66 commercialized DURECT 66 Regenerative Cells 66 KYTHERA Biopharmaceuticals Inc. 66 Liposomal 66 candidate Zelrix 66 OvaRex ® MAb 66 Combivir Kivexa 66 Inc. Nasdaq CRTX 66 Nucleic Acid Detection Immunoassay 66 developing TB4 66 tartrate Inhalation Solution 66 MTP inhibitor 66 arsenic trioxide injection 66 Glufosfamide 66 rasagiline tablets 66 Shigatoxin producing E. coli 66 Locteron exclusively 66 LEUKINE 66 PATHFINDER R 66 OMRIX Biopharmaceuticals Inc. 66 Chimigen TM 66 Hemospan 66 oral taxane 66 histone deacetylase inhibitor 66 Preclinical Development 66 Announces License Agreement 66 Oral Calcitonin 66 investigational hepatitis B 66 BrachySil TM 66 Augment ™ 66 topical antifungal 66 Occlusin TM 66 P#X# antagonist 66 individualized cellular immunotherapy 66 Launches Generic Version 66 SYN# 66 Azedra ™ 66 external counterpulsation systems 66 Commences Phase 66 Vaccine Adjuvant 66 OTCBB QTXB 66 CINTREDEKIN BESUDOTOX 66 initiated Phase Ib 66 BrachySil ™ 66 syndrome overactive bladder 66 diarrhea predominant irritable 66 leading oral taxane 66 itraconazole Sporanox 66 intravenous AAT 66 Valortim TM 66 TAXUS Element Paclitaxel Eluting 66 CORT # estimates 66 human IgG1 monoclonal 66 thetreatment 66 MacuSight 66 defensin mimetic antibiotic 66 recombinant subunit vaccine 66 investigational immunotherapy 66 phase IIb clinical 66 Nexavar ® 66 Abbokinase 66 RNA interference RNAi therapeutics 66 octreotide acetate 66 R famotidine 66 YONDELIS R 66 treat lupus renal 66 induced mucositis 66 synthetic peptide containing 66 vivo validation 66 Kamada AAT 66 Genitope Corporation 65 GVAX R 65 faropenem medoxomil 65 Nasdaq PGNX 65 alfimeprase direct 65 liposomal delivery 65 novel emulsion formulation 65 researches develops licenses 65 include Healive 65 HDAC Inhibitor 65 phenylketonuria PKU developed 65 small molecule glucokinase 65 www.nanoviricides.com 65 Pharma Merck Serono 65 SPRYCEL ® 65 abobotulinumtoxinA 65 Genotyping Test 65 Mylan Receives Approval 65 HP Acthar Gel repository 65 Pentad TM 65 dimebon latrepirdine 65 progressive metastatic prostate 65 nasal decolonization 65 Clinical Trial Results 65 Esmya 65 Ozarelix 65 factor VIIa 65 GATTEX TM 65 IND Application 65 Uracyst R Test 65 CAPHOSOL R 65 multi kinase inhibitor 65 Trophos 65 Prodarsan ® 65 candidate SILENOR TM 65 gastro intestinal inflammation 65 biosurgical 65 SYGNIS 65 oxybutynin gel 65 tafamidis 65 interferon alpha IFN 65 sorafenib tablets 65 Microplasmin 65 Bioral Amphotericin B 65 oritavancin semi 65 oral transdermal 65 systemically administered 65 Altropane 65 Endotis 65 Kelly Luethje #-#-# 65 MP4 molecule 65 UltiMAb ® 65 Cytogen marketed 65 therefore therapeutically equivalent 65 Oracea ® 65 docetaxel Taxotere ® 65 sublingual tablet 65 liver resection surgeries 65 POTELLIGENT ®